An analysis of breakthrough seizures and related factors in paediatric epilepsy patients

Hina Khalid1, Saeed Arif2, Asif Hashmat2

  • 1Department of Pediatrics, Combined Military Hospital, Lahore Medical College, Lahore, Pakistan.

Insights

Breakthrough seizures are common in children with epilepsy, affecting over half of those studied. Young age, low income, and poly-pharmacy increase the risk of these seizures.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Research
  • Clinical Medicine

Background:

  • Epilepsy is a chronic neurological disorder affecting millions of children worldwide.
  • Breakthrough seizures, occurring despite treatment, pose a significant challenge in pediatric epilepsy management.
  • Understanding the factors contributing to breakthrough seizures is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To determine the frequency of breakthrough seizures in pediatric epilepsy patients.
  • To identify socio-demographic and clinical factors associated with breakthrough seizures in children.
  • To inform clinical practice and future research in pediatric epilepsy.

Main Methods:

  • A cross-sectional study was conducted involving 450 children aged 2-12 years diagnosed with epilepsy.
  • Data was collected on seizure history, socio-demographics, epilepsy duration, and medication use (poly-pharmacy).
  • Statistical analysis was performed using SPSS 23 to identify factors associated with breakthrough seizures.

Main Results:

  • Over half of the subjects (50.4%) experienced breakthrough seizures.
  • Factors significantly associated with higher odds of breakthrough seizures included younger age, low family income, and the need for poly-pharmacy (multiple anti-epileptic drugs).
  • Boys constituted 57.6% of the study population, with a mean age of 6.35 years.

Conclusions:

  • The incidence of breakthrough seizures in epileptic children is high, even with previously effective anticonvulsant medications.
  • Younger children, those from low-income families, and patients on poly-pharmacy are at increased risk.
  • Further research is needed to develop targeted interventions for preventing breakthrough seizures in vulnerable pediatric epilepsy populations.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
316
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
633
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
485